Tag: Hepatitis
Glecaprevir-Pibrentasvir Effective Treatment for HCV Genotypes 1, 3
Once-daily treatment for eight or 12 weeks yields high rates of sustained virologic response
Psoriasis Remission Described After Hepatitis C Virus Treatment
Case report: After initiation of ledipasvir-sofosbuvir, HCV RNA decreased, and skin lesions improved
Pharmacies Can Up Access to Direct-Acting Antivirals for Hep C
Collaboration with local specialty pharmacy linked to reduced delays in therapy, lower rates of denial
Hepatitis B Vaccination Often Missed Among HIV Patients
More than one-third of adult HIV patients receiving medical care have not been vaccinated
Best Practice Advice Issued for Hep B Vaccination, Screening
All unvaccinated adults at risk for infection should be vaccinated; screening recommended for at-risk
Hepatitis B Viral Load, Surface Antigen May ID Liver Cancer Risk
Increased risk of liver cancer linked to hepatitis B DNA, surface antigen in a dose-response manner
For Hepatitis B Patients, Aspirin Tied to Lower Risk of HCC
5 years of aspirin therapy linked to significantly lower incidence of hepatocellular carcinoma
High Sustained Response Rate for Glecaprevir, Pibrentasvir in HCV
12-week therapy results in high rate of sustained virologic response for patients with CKD, hepatitis C
High Coffee Intake Tied to Lower Mortality in HIV/HCV
Those who drink at least 3 cups daily have 50 percent lower all-cause mortality
State Laws Can Promote Hepatitis C Virus Screening
Mandating health care providers to offer screening increases screening rates, linkage to care
